Melanotan 2 PEN 20 mg

Melanotan 2 pen 20 mg – product information

Melanotan 2 pen 20 mg is a research peptide in the form of a solution housed in a pen-type applicator for laboratory applications, comparative analyses and reference procedures. Melanotan 2, also referred to as Melanotan II or MT-II, is described in the literature as a synthetic cyclic analogue of α-MSH, or α-melanocyte-stimulating hormone. From a scientific characterisation perspective, this molecule remains associated with studies on melanocortin receptors, the structure of α-MSH analogues and the relationship between cyclic peptide structure and receptor activity.

In the scientific literature, Melanotan 2 pen 20 mg is described primarily in relation to the melanocortin system, which includes the MC1R, MC2R, MC3R, MC4R and MC5R receptors, a member of the G-protein-coupled receptor family. Publications on melanocortin receptor ligands indicate that synthetic α-MSH analogues, including Melanotan II, have been developed as compounds with increased stability and more potent biological activity relative to natural melanocortin peptides. Thus, Melanotan 2 pen 20 mg can be presented as a research reagent for receptor and comparative analyses.

See also Melanotan reagent 10 mg vial

Melanotan 2 pen 20 mg - study profile and laboratory significance

At the molecular level, Melanotan II is described as a non-selective melanocortin receptor agonist, meaning that it can interact with more than one receptor subtype in research models. Of particular relevance here are analyses related to MC1R, pigmentation and melanocytes, as well as models involving MC3R and MC4R receptors used in neurobiological and metabolic studies. This approach allows Melanotan 2 pen 20 mg to be described as a research peptide for melanocortin receptor analyses, without reference to therapeutic or applied applications.

The PEN format refers to a laboratory applicator designed for precise and reproducible measurement of the reagent in controlled test procedures. In the case of Melanotan 2 pen 20 mg, the peptide solution is housed in a RUO applicator, which facilitates standardisation of work with test material, comparative analyses and repeatability between laboratory test steps. 

Sources:

1. Ligands for Melanocortin Receptors
2. The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases
3. Novel approaches to the design of bioavailable melanotropins
4. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
5. Melanotan II injection resulting in systemic toxicity and rhabdomyolysi

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.